Will Radiopharmaceutical Company AAA Be M&A Fodder For Novartis?

Novartis, which is focused on securing bolt-on acquisitions rather than mega-M&A to bolster its pipeline, might have found the right target in French radiopharmaceutical company Advanced Accelerator Applications – if rumors are to be believed.